newsfilter
← Latest News
PR Newswire·

Results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published

STOCKHOLM, Nov. 18, 2021 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that results from the investigator-initiated phase II clinical study in patients with squamous cell carcinoma (SCC) has been published in JAMA Dermatology by Ki